"Urgent care services are temporarily closed. Pharmacy hours: Monday through Friday from 8:30 am – 5:00 pm. For questions, please call 800-777-7904 (TTY 711). With the outbreak of COVID-19, we want to ensure we are ready to care for the most critically ill patients while also meeting your needs. New or previously scheduled appointments may be changed to a video or phone visit so you can stay home and still receive quality care. Most prescriptions can be ordered via mail. Visit our website to schedule a virtual appointment, request mail order for your prescription or send an email to your doctor’s office. Our doctors are postponing elective or non-urgent surgeries and procedures."

During the past decade, Kaiser Permanente - Kensington Medical Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 6 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 6 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente - Kensington Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "SWOG Cancer Research Network" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente - Kensington Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Canadian Cancer Trials Group (CCTG)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente - Kensington Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Anatomic Stage II Breast Cancer AJCC v8" (2 trials) and "Anatomic Stage IIA Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Kaiser Permanente - Kensington Medical Center" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente - Kensington Medical Center" are "Other" (19 trials), "Drug" (17 trials), "Biological" (10 trials), "Procedure" (6 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Quality-of-Life Assessment" (8 trials), "Paclitaxel" (5 trials), "Questionnaire Administration" (5 trials) and "Docetaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente - Kensington Medical Center" are 18 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente - Kensington Medical Center". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Kaiser Permanente - Kensington Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente - Kensington Medical Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".